Morgan Newman

Team Cervivor Attends ASCO 2024

The American Society of Clinical Oncology (ASCO) Annual Meeting is a premier event in the oncology community, gathering thousands of professionals from around the globe to discuss groundbreaking research, innovative treatments, and the future of cancer care. This year, Team Cervivor attended ASCO 2024, marking a significant milestone for our organization and highlighting the critical role of patient advocates in the fight against cancer.

What is ASCO?
ASCO, founded in 1964, is a leading professional organization for physicians and oncology professionals. Its mission is to conquer cancer through research, education, and the promotion of the highest quality patient care. The annual ASCO meeting is the largest of its kind, offering a platform for the latest scientific advancements, policy discussions, and networking opportunities. Attendees include oncologists, researchers, pharmaceutical representatives, and patient advocates, all united in their dedication to improving cancer care.

Our presence at ASCO 2024 was a testament to the growing recognition of the importance of patient voices in shaping cancer care and research. Here’s why our participation matters:

  1. Amplifying Patient Voices: As patient advocates, we bring the perspectives and experiences of those directly affected by cervical cancer. Our stories and insights are invaluable in guiding research priorities and improving patient care practices.
  2. Cultivating Collaboration: Attending ASCO allows us to collaborate with researchers, clinicians, and other advocacy groups. These interactions help us stay informed about the latest advancements and ensure that patient needs are at the forefront of scientific discussions.
  3. Promoting Awareness and Education: By engaging with the oncology community, we can spread awareness about cervical cancer, highlight the importance of prevention and early detection, and share our educational resources. Our presence at ASCO reinforces the message that cervical cancer is preventable and treatable when caught early.
  1. Influencing Policy and Research: Our participation at ASCO provides opportunities to advocate for policies that benefit cervical cancer patients and survivors. We can also contribute to shaping research agendas by emphasizing areas that require more attention, such as disparities in cancer care and the psychosocial impacts of the disease.

Team Cervivor Listed from Left to Right: Morgan Newman, MSW, Community Engagement Liaison; Tamika Felder, Founder & Chief Visionary; and Kimberly Williams, MHCM, Chief Diversity Equity & Inclusion Officer

Highlights from ASCO 2024
ASCO 2024 was a whirlwind of inspiring sessions, groundbreaking research presentations, and meaningful interactions. Here are some highlights from our experience:

– Networking Opportunities: We connected with oncologists, researchers, and fellow advocates, nurturing relationships that will strengthen our advocacy efforts. These connections are crucial for creating a supportive network dedicated to cervical cancer eradication.

– Media and Outreach: We participated in interviews, highlighting the importance of patient advocacy and the work we do. These media opportunities allowed us to reach a broader audience and amplify our message.

We also had the honor of having our Founder and Chief Visionary, Tamika Felder, speak on a crucial panel titled, “Bridging the Gap in Cancer Care for Adolescents and Young Adults” hosted by The Atlantic. This enlightening session shed light on the challenges faced by the nearly 1.5 million adolescents and young adults diagnosed with cancer each year. Addressing issues such as work, health insurance, school, fertility, and emotional distress, the panel explored the unique cancer biology of this age group and the lack of survival improvements compared to other age demographics. Tamika, alongside other survivors, oncologists, and advocates, shared her journey and insights, emphasizing the importance of tailored care and pioneering local programs that support the distinct needs of young cancer patients. Her participation underscored Team Cervivor’s commitment to advocating for comprehensive and compassionate cancer care for all age groups.

Attending ASCO 2024 was more than just an opportunity to learn and network; it was a chance to reaffirm our commitment to the mission to end cervical cancer. We left the conference inspired and energized, ready to continue our mission with renewed vigor. Our presence at ASCO underscores the vital role of patient advocates in the oncology community, and we are proud to be a voice for cervical cancer patients and survivors worldwide.

As we move forward, we will leverage the knowledge and connections gained at ASCO to enhance our educational programs, support initiatives, and advocacy efforts. Together, we can make a difference in the lives of those affected by cervical cancer and work towards a future free of this preventable disease. Stay tuned for more updates from Team Cervivor and join us in our journey to eradicate cervical cancer. Together, we are stronger, and together, we can achieve a world without cervical cancer.

Honors in Advocacy for our Leaders in the Mission to End Cervical Cancer

In the relentless mission to end cervical cancer, every victory, every recognition, is a puzzle piece of hope, a testament to the dedication of those who tirelessly advocate for progress. Today, we are honored and humbled to celebrate the remarkable achievements of three extraordinary individuals who have devoted their lives to championing the cause of cancer patients, survivors, and advocates.

Tamika Felder, Founder & Chief Visionary

At the forefront of our celebration is Tamika Felder, our Founder and Chief Visionary, whose journey from patient to nonprofit founder has been nothing short of inspiring. In 2001, Tamika faced a daunting diagnosis of cervical cancer, a moment that would change her life forever. Determined to turn her personal struggle into a source of strength for others, Tamika founded Cervivor in 2005, an organization dedicated to educating and empowering cervical cancer patients and survivors to share their stories and make a difference.

For the past 19 years, Tamika has been a trailblazer in the mission to end cervical cancer, always advocating for the voices of patients and survivors to be heard. Her commitment and relentless efforts have earned her the incredible honor of being appointed to the National Cancer Advisory Board by President Joe Biden. This appointment is not only a testament to Tamika’s extraordinary leadership but also a recognition of the vital role that she and Cervivor play in shaping the future of cancer research, treatment, and prevention.

The National Cancer Advisory Board plays a crucial role in guiding the Director of the National Cancer Institute in setting the course for the national cancer research program. As we work towards President Biden’s ambitious goal of ending cancer as we know it through initiatives like the Cancer Moonshot, Tamika’s appointment ensures that the voices of cervical cancer patients and survivors will be heard loud and clear at the highest levels of decision-making.

Morgan Newman, MSW, Community Engagement Liaison

We are also thrilled to celebrate the achievements of Morgan Newman, our Community Engagement Liaison, who has been selected as a patient advocate member for the National Cancer Institute (NCI) Gynecologic Cancer Steering Committee (GCSC) Cervical Task Force (CTF). Morgan’s dedication to ensuring that patient voices are integrated into the development and evaluation of clinical trials is truly commendable. Through her involvement in these committees, Morgan is helping to shape the future of gynecologic cancer research and treatment, ensuring that the needs and perspectives of patients are always front and center.

Kimberly Williams, MHCM, Chief Diversity Equity & Inclusion Officer

Last but certainly not least, we extend our heartfelt congratulations to Kimberly Williams, our Chief Diversity Equity and Inclusion Officer, for her continuous role as a patient advocate member for the Cervix/Vulva Cancer Committee for NRG Oncology. Kimberly’s tireless advocacy efforts have been instrumental in improving the clinical research process and ensuring that patient perspectives are always prioritized. Her recent appointment to the Diversity, Equity, and Inclusion Committee further underscores her commitment to advancing equity and inclusion in cancer research and treatment for all.

As we celebrate these remarkable achievements, we are reminded of the power of advocacy and the incredible impact that individuals like Tamika, Morgan, and Kimberly can have in the mission to end cervical cancer. Their dedication, passion, and advocacy serve as an inspiration to us all, and we are proud to stand alongside them in the quest for a world free from cervical cancer.

To learn more about Tamika Felder’s appointment to the National Cancer Advisory Board, please see the official press release from the White House [here].